PEOPLEIN LIMITED (PPE)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

PPE - PEOPLEIN LIMITED

Year End: June
GICS Industry Group : Commercial & Professional Services
Debt/EBITDA: 2.15
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.925

22 Jul
2024

-0.020

OPEN

$0.93

-2.12%

HIGH

$0.95

56,123

LOW

$0.93

TARGET
$1.255 35.7% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
APM . LVH . SEK . SIO . XF1 .
FNARENA'S MARKET CONSENSUS FORECASTS
PPE: 1
Title FY22
Actual
FY23
Actual
FY24
Forecast
FY25
Forecast
EPS (cps) xxx 18.8 13.1 xxx
DPS (cps) xxx 14.0 5.8 xxx
EPS Growth xxx 1.1% - 30.6% xxx
DPS Growth xxx N/A - 58.6% xxx
PE Ratio xxx N/A 7.0 xxx
Dividend Yield xxx N/A 6.3% xxx
Div Pay Ratio(%) xxx 74.5% 44.4% xxx

Dividend yield today if purchased 3 years ago: 3.24%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

15.22

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 04/03 - ex-div 3c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx18.8
DPS All xxxxxxxxxxxxxxx14.0
Sales/Revenue xxxxxxxxxxxxxxx1,182.7 M
Book Value Per Share xxxxxxxxxxxxxxx154.2
Net Operating Cash Flow xxxxxxxxxxxxxxx64.5 M
Net Profit Margin xxxxxxxxxxxxxxx1.60 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx12.79 %
Return on Invested Capital xxxxxxxxxxxxxxx8.42 %
Return on Assets xxxxxxxxxxxxxxx4.77 %
Return on Equity xxxxxxxxxxxxxxx12.79 %
Return on Total Capital xxxxxxxxxxxxxxx13.51 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx47.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx34 M
Long Term Debt xxxxxxxxxxxxxxx79 M
Total Debt xxxxxxxxxxxxxxx113 M
Goodwill - Gross xxxxxxxxxxxxxxx149 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx40 M
Price To Book Value xxxxxxxxxxxxxxx1.52

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx9.1 M
Capex % of Sales xxxxxxxxxxxxxxx0.77 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx1,130 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.5

No. Of Recommendations

2
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

27/02/2024

3

Downgrade to Hold from Add

$1.05

13.51%

Margins continue to decline in the 1H for PeopleIN due to a challenging economic environment, explains Morgans. By way of explanation, management noted a decline in contract rates, permanent recruitment fees and government subsidies.

While these explanations are not new to the broker, the level of margin degradation quarter-on-quarter has surprised, largely due to the declining contract rate. As conditions are unlikely to improve in the next year, the rating is downgraded to Hold from Add.

While in line with the consensus forecast, earnings (EBITDA) for the half fell by -38% on the previous corresponding period. No quantitative guidance was provided.

The target falls to $1.05 from $1.85.

FORECAST
Morgans forecasts a full year FY24 dividend of 6.10 cents and EPS of 13.20 cents.
Morgans forecasts a full year FY25 dividend of 6.60 cents and EPS of 11.90 cents.

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Wilsons

xx/xx/xxxx

3

xxxxxx xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Petra Capital

07/03/2024

1

Buy

$1.80

94.59%

While PeopleIN's underlying 1H earnings (EBITDA) of $20.2m were nearly half Petra Capital's $40.6m forecast for FY24, materially negative operating cash flow (OCF) drove a corresponding increase in gearing.

The analyst's net debt to earnings forecast for June 30 this year is 2.0 times compared to 1.5 times previously, which is at the top end of Petra Capital's comfort range, but still well below the company's debt covenants.

Reflecting changes in business mix to lower margin work across all divisions, the earnings margin fell by -210bps to 3.3%. Higher margin private sector work declined in Health & Community, while permanent recruitment in Professional Services also weakened.

The broker anticipates improved 2H cash flows and relatively stable earnings. The Buy rating is maintained and the target falls to $1.80 from $1.90.

FORECAST
Petra Capital forecasts a full year FY24 dividend of 6.50 cents and EPS of 21.20 cents.
Petra Capital forecasts a full year FY25 dividend of 9.00 cents and EPS of 21.60 cents.

PPE STOCK CHART